ADC Drug Advances in Non-Small Cell Lung Cancer
Introduction Despite rapid advancements in targeted therapy for NSCLC (non-small cell lung cancer), there remains an unmet need. This article summarizes the latest progress in targeted therapies for NSCLC involving Her2, Her3, and Trop-2 to inform readers. NSCLC and ADC Whether through targeted therapy or immunotherapy, the number of lung cancer patients benefiting remains limited, … Read more